BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹5.65 Cr | ₹5.09 Cr | ₹5.07 Cr | ₹4.69 Cr | ₹4.07 Cr |
What is the latest Long Term Provisions ratio of BAL PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹5.65 Cr |
| Mar2024 | ₹5.09 Cr |
| Mar2023 | ₹5.07 Cr |
| Mar2022 | ₹4.69 Cr |
| Mar2021 | ₹4.07 Cr |
How is Long Term Provisions of BAL PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.65 Cr | 10.99 | |
| Mar2024 | ₹5.09 Cr | 0.36 | |
| Mar2023 | ₹5.07 Cr | 7.97 | |
| Mar2022 | ₹4.69 Cr | 15.47 | |
| Mar2021 | ₹4.07 Cr | - | |
Compare Long Term Provisions of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹114.4 Cr | -0.8% | 3.4% | -18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -0.8% |
3.4% |
-18.8% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses